Second-hand luxury marketplace The RealReal, Inc. showed progress in important metrics that point to profitability on the horizon in its third quarter results, IPO Edge Editor-in-Chief John Jannarone told Cheddar […]

NEW YORK–(BUSINESS WIRE)–Allianz Global Investors (“AllianzGI”), one of the world’s leading active investment managers, announced today that the AllianzGI Artificial Intelligence & Technology Opportunities Fund (the “Fund”) has completed its […]

PHILADELPHIA–(BUSINESS WIRE)–Osprey Technology Acquisition Corp. (the “Company”), a technology-focused special purpose acquisition entity formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization […]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs […]

BUFFALO GROVE, Ill.–(BUSINESS WIRE)–Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today the closing of its previously […]

LA JOLLA, Calif.–(BUSINESS WIRE)–Silvergate Capital Corporation (“Silvergate” or the “Company”) announced the launch of its initial public offering of 3,744,307 shares of Class A common stock. Silvergate is offering 770,000 […]

Social Capital Hedosophia Holdings Corp. to Begin trading as Virgin Galactic Holdings, Inc. on Monday By John Jannarone Shares of Virgin Galactic Holdings, Inc., like seats on its commercial spaceships, […]

Amazon.com Inc.’s earnings miss and weak holiday forecast elicited a similar reaction seen by many recent tech unicorns, IPO Edge Editor-in-Chief John Jannarone told Cheddar TV in a live interview. […]

BUFFALO GROVE, Ill.–(BUSINESS WIRE)–Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that it has priced its […]

CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that, in […]